| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 5.665 | 14.891 | 46.646 | 97.786 | 116.318 |
| Total Income - EUR | - | - | - | - | - | 5.665 | 14.891 | 46.646 | 97.817 | 118.341 |
| Total Expenses - EUR | - | - | - | - | - | 142 | 4.910 | 6.995 | 19.055 | 30.737 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 5.523 | 9.980 | 39.651 | 78.762 | 87.604 |
| Net Profit/Loss - EUR | - | - | - | - | - | 5.357 | 9.484 | 38.578 | 77.775 | 84.114 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Vlad Hurduc Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 47 | 1.448 | 830 | 3.168 | 2.071 |
| Current Assets | - | - | - | - | - | 5.471 | 8.441 | 38.732 | 79.137 | 85.313 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 870 | 3.309 | 32.196 | 48.789 | 47.719 |
| Cash | - | - | - | - | - | 4.601 | 5.132 | 6.536 | 1.034 | 403 |
| Shareholders Funds | - | - | - | - | - | 5.399 | 9.533 | 38.626 | 77.823 | 84.162 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 120 | 356 | 936 | 4.482 | 3.485 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vlad Hurduc Med S.r.l.